Literature DB >> 15311039

Conservative management of hyperplastic and multicentric nephroblastomatosis.

Francesco Cozzi1, Amalia Schiavetti, Denis A Cozzi, Francesco Morini, Stefania Uccini, Paolo Pierani, Ascanio Martino.   

Abstract

PURPOSE: The treatment of hyperplastic nephroblastomatosis remains controversial. We report the advantages of conservative management of hyperplastic and multicentric nephroblastomatosis associated with unilateral Wilms tumor (WT).
MATERIALS AND METHODS: During the last 10 years 48 children with unilateral WT were consecutively treated at our 2 institutions. Children with multiple solid renal masses on imaging were treated with 2-drug chemotherapy until disappearance of the lesions. Stabilization or progression of the lesions despite chemotherapy, as well as heterogeneity of the lesions on imaging, prompted nephron sparing surgery (NSS).
RESULTS: Three female infants (12, 13 and 20 months old, respectively) presented with multiple solid renal tumors at imaging. Despite chemotherapy, small and unilateral WT developed in 2 cases of hyperplastic nephroblastomatosis, which was excised. One of these infants subsequently presented with a small contralateral metachronous WT, which was excised. Both infants are disease-free with 2 normal kidneys at followup of 6 and 2 years, respectively. The third infant, who presented with unilateral multicentric WT and unilateral hyperplastic nephroblastomatosis nodules, was successfully treated with preoperative chemotherapy and enucleation of 5 tumors. Subsequently, nephrectomy was performed at another institution because the abnormal kidney outline due to NSS was misinterpreted as a recurrence of WT. She was lost to followup.
CONCLUSIONS: Hyperplastic and multicentric nephroblastomatosis is not a rare lesion and is most often associated, either initially or subsequently, with WT. In some infants with multiple solid renal masses on imaging chemotherapy and for developing WT NSS may safely allow maximum sparing of the parenchyma of both kidneys.

Entities:  

Mesh:

Year:  2004        PMID: 15311039     DOI: 10.1097/01.ju.0000134883.12993.82

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Wilms tumour: prognostic factors, staging, therapy and late effects.

Authors:  Sue C Kaste; Jeffrey S Dome; Paul S Babyn; Norbert M Graf; Paul Grundy; Jan Godzinski; Gill A Levitt; Helen Jenkinson
Journal:  Pediatr Radiol       Date:  2007-11-17

2.  Perilobar nephroblastomatosis: natural history and management.

Authors:  S Stabouli; N Printza; J Dotis; A Matis; D Koliouskas; N Gombakis; F Papachristou
Journal:  Case Rep Pediatr       Date:  2014-07-09

3.  Prognostic Factors of Wilms' Tumor Complicated with Nephroblastomatosis.

Authors:  Hong-Chuan Niu; Wei-Ping Zhang; Ning Sun; Le-Jian He; Yun Peng
Journal:  Chin Med J (Engl)       Date:  2015-09-20       Impact factor: 2.628

4.  Nephroblastomatosis and wilms tumor: dangerous liaisons.

Authors:  Lisieux Eyer de Jesus; Celine Fulgencio; Thais Cardoso Leve; Samuel Dekermacher
Journal:  Int Braz J Urol       Date:  2022 Jan-Feb       Impact factor: 1.541

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.